HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spinal cord mechanisms mediating behavioral hyperalgesia induced by neurokinin-1 tachykinin receptor activation in the rostral ventromedial medulla.

Abstract
Hyperalgesia in animal injury models is linked to activation of descending raphespinal modulatory circuits originating in the rostral ventromedial medulla (RVM). A neurokinin-1 (NK-1) receptor antagonist microinjected into the RVM before or after inflammation produced by complete Freund's adjuvant (CFA) resulted in an attenuation of thermal hyperalgesia. A transient (acute) or a continuous infusion of Substance P (SP) microinjected into the RVM of non-inflamed animals led to similar pain hypersensitivity. Intrathecal pretreatment or post-treatment of a 5-HT3 receptor antagonist (Y-25130 or ondansetron) blocked the SP-induced hyperalgesia. The SP-induced hyperalgesia was both GABA(A) and NMDA receptor-dependent after pre- and post-treatment with selective antagonists at the spinal level. A microinjection of SP into the RVM also led to increased NMDA NR1 receptor subunit phosphorylation in spinal cord tissue. The GABA(A) receptor-mediated hyperalgesia involved a shift in the anionic gradient in dorsal horn nociceptive neurons and an increase in phosphorylated NKCC1 protein (isoform of the Na-K-Cl cotransporter). Following a low dose of SP infused into the RVM, intrathecal muscimol (GABA(A) agonist) increased SP-induced thermal hyperalgesia, phosphorylated NKCC1 protein expression, and NMDA NR1 subunit phosphorylation in the spinal cord. The thermal hyperalgesia was blocked by intrathecal gabazine, the GABA(A) receptor antagonist, and MK-801, the NMDA receptor channel blocker. These findings indicate that NK-1 receptors in the RVM are involved in SP-induced thermal hyperalgesia, this hyperalgesia is 5-HT3-receptor dependent at the spinal level, and involves the functional interaction of spinal GABA(A) and NMDA receptors.
AuthorsS C Lagraize, W Guo, K Yang, F Wei, K Ren, R Dubner
JournalNeuroscience (Neuroscience) Vol. 171 Issue 4 Pg. 1341-56 (Dec 29 2010) ISSN: 1873-7544 [Electronic] United States
PMID20888891 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2010. Published by Elsevier Ltd.
Chemical References
  • Bridged Bicyclo Compounds, Heterocyclic
  • Excitatory Amino Acid Antagonists
  • GABA Agents
  • Oxazines
  • Pyridazines
  • Receptors, Neurokinin-1
  • Serotonin Antagonists
  • 3,5-bis(trifluoromethyl)benzyl N-acetyltryptophan
  • Muscimol
  • Substance P
  • Ondansetron
  • Dizocilpine Maleate
  • azasetron
  • Tryptophan
  • Freund's Adjuvant
  • gabazine
Topics
  • Animals
  • Behavior, Animal
  • Bridged Bicyclo Compounds, Heterocyclic (pharmacology)
  • Disease Models, Animal
  • Dizocilpine Maleate (pharmacology)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Interactions
  • Excitatory Amino Acid Antagonists (pharmacology)
  • Freund's Adjuvant
  • GABA Agents (pharmacology)
  • Hyperalgesia (etiology, pathology, prevention & control)
  • In Vitro Techniques
  • Inflammation (chemically induced, complications)
  • Male
  • Medulla Oblongata (drug effects, metabolism)
  • Membrane Potentials (drug effects)
  • Microinjections (methods)
  • Muscimol (pharmacology)
  • Ondansetron (pharmacology)
  • Oxazines (pharmacology)
  • Pain Measurement
  • Pain Threshold (drug effects, physiology)
  • Posterior Horn Cells (drug effects, physiology)
  • Pyridazines (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Reaction Time (drug effects, physiology)
  • Receptors, Neurokinin-1 (metabolism)
  • Serotonin Antagonists (pharmacology)
  • Spinal Cord (cytology, metabolism)
  • Substance P (pharmacology)
  • Tryptophan (analogs & derivatives, pharmacology)
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: